You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

siltuximab

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Siltuximab
  • Nantes, France
    CHU de Nantes
Jan 24, 2023

Multiple Myeloma, AL Amyloidosis Trial in New York (Siltuximab, The M.D. Anderson Symptom Inventory (MDASI))

Active, not recruiting
  • Multiple Myeloma
  • AL Amyloidosis
  • Siltuximab
  • The M.D. Anderson Symptom Inventory (MDASI)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Schwannomatosis, Schwannomas, Pain, Chronic Trial in Boston (Siltuximab, Erenumab-Aooe, Siltuximab Matching Placebo)

Not yet recruiting
  • Schwannomatosis
  • +2 more
  • Siltuximab
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 5, 2023

Large Granular Lymphocyte Leukemia Trial in Tampa (Siltuximab)

Recruiting
  • Large Granular Lymphocyte Leukemia
  • Siltuximab
  • Tampa, Florida
    Moffitt Cancer Center
Mar 30, 2022

Cytokine Release Syndrome, ICANS, Lymphoma, Non-Hodgkin Trial in Birmingham (Siltuximab)

Recruiting
  • Cytokine Release Syndrome
  • +4 more
  • Siltuximab
  • Birmingham, Alabama
    University of Alabama at Birmingham
Nov 17, 2021

Schizophrenia, Psychotic Disorders Trial in Augusta (Siltuximab, normal saline)

Recruiting
  • Schizophrenia
  • Psychotic Disorders
  • Siltuximab
  • normal saline
  • Augusta, Georgia
    Augusta University
Jul 27, 2021

Idiopathic Multicentric Castleman's Disease Trial in Lansing (Siltuximab)

Terminated
  • Idiopathic Multicentric Castleman's Disease
  • Siltuximab
  • Lansing, Michigan
    Edward W. Sparrow Hospital
Apr 15, 2021

Acute Respiratory Distress Syndrome, Lung Diseases, Pneumonia Trial in Lansing, Charlotte (Siltuximab, Normal Saline)

Terminated
  • Acute Respiratory Distress Syndrome
  • +4 more
  • Siltuximab
  • Normal Saline
  • Lansing, Michigan
  • +1 more
Apr 15, 2021

COVID-19 Trial in Spain (Siltuximab, Methylprednisolone)

Unknown status
  • COVID-19
  • Badalona, Spain
  • +3 more
Apr 16, 2020

COVID-19 Trial in Belgium (Usual Care, Anakinra, Siltuximab)

Completed
  • COVID-19
  • Usual Care
  • +3 more
  • Brugge, Belgium
  • +14 more
Sep 28, 2021

High-risk Smoldering Multiple Myeloma Trial in Worldwide (Siltuximab, Placebo)

Completed
Has Results
  • High-risk Smoldering Multiple Myeloma
  • Siltuximab
  • Placebo
  • Chicago, Illinois
  • +39 more
Jan 23, 2020

Type 1 Diabetes Trial in Seattle (Siltuximab)

Completed
Has Results
  • Type 1 Diabetes
  • Siltuximab
  • Seattle, Washington
    Benaroya Research Institute
Oct 5, 2018

Multiple Myeloma Trial in Worldwide (Siltuximab, Bortezomib, Placebo)

Completed
Has Results
  • Multiple Myeloma
  • Siltuximab
  • +3 more
  • Greenbrae, California
  • +83 more
Nov 7, 2019

Multicentric Castleman's Disease Trial in Worldwide (Siltuximab)

Completed
Has Results
  • Multicentric Castleman's Disease
  • Siltuximab
  • Little Rock, Arkansas
  • +25 more
Apr 25, 2018

Multicentric Castleman's Disease Trial in Worldwide (Siltuximab, Placebo, Best Supportive Care (BSC))

Completed
Has Results
  • Multicentric Castleman's Disease
  • Siltuximab
  • +2 more
  • Little Rock, Arkansas
  • +56 more
Feb 22, 2018

Myeloma Trial in Houston (Lenalidomide, Bortezomib, Siltuximab)

Completed
Has Results
  • Myeloma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 2, 2015

Myelodysplastic Syndrome Trial in Worldwide (Siltuximab, Placebo, Best supportive care (BSC))

Terminated
Has Results
  • Myelodysplastic Syndrome
  • Siltuximab
  • +2 more
  • Tampa, Florida
  • +22 more
Sep 24, 2014

Cancer, Prostate Trial in Worldwide (Mitoxantrone, Siltuximab, Prednisone)

Terminated
Has Results
  • Cancer, Prostate
  • Norwalk, Connecticut
  • +35 more
Aug 18, 2014

Multiple Myeloma Trial in Japan (Siltuximab)

Terminated
  • Multiple Myeloma
  • Siltuximab
  • Isehara, Japan
  • +4 more
May 16, 2014

Multiple Myeloma Trial in Netherlands, United States (Siltuximab, Dexamethasone)

Completed
  • Multiple Myeloma
  • Duarte, California
  • +12 more
May 13, 2014